Vassilev, Alexei O
Targeting JAK3 and BTK tyrosine kinases with rationally-designed inhibitors. [electronic resource]
- Current drug targets Mar 2006
- 327-43 p. digital
Publication Type: Journal Article; Review
1389-4501
10.2174/138945006776054997 doi
Agammaglobulinaemia Tyrosine Kinase
Animals
Autoimmune Diseases--drug therapy
Diabetes Mellitus, Type 1--drug therapy
Drug Delivery Systems
Drug Design
Enzyme Inhibitors--pharmacology
Humans
Janus Kinase 3
Neoplasms--complications
Organ Transplantation--physiology
Protein-Tyrosine Kinases--antagonists & inhibitors